STAT3 and neoplasm: To further demonstrate that VEGF-A/STAT3 is involved in inhibition of regorafenib-dependent tumor migration in TNBC cells, we transfected VEGF-A or STAT3 overexpression plasmid into MDA-MB-231 cells and analyzed the migration ability of MDA-MB-231 cells after regorafenib treatment.